[1]徐 敏,王彦舟,张 华.全身炎性反应指数联合控制营养状况评分对结肠癌患者预后的预测价值[J].陕西医学杂志,2023,52(11):1558-1562,1566.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
　XU Min,WANG Yanzhou,ZHANG Hua.Predictive value of SIRI combined with CONUT score in prognosis of patients with colon cancer[J].,2023,52(11):1558-1562,1566.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
点击复制

全身炎性反应指数联合控制营养状况评分对结肠癌患者预后的预测价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年11期
页码:
1558-1562,1566
栏目:
临床研究
出版日期:
2023-11-05

文章信息/Info

Title:
Predictive value of SIRI combined with CONUT score in prognosis of patients with colon cancer
作者:
徐 敏1; 王彦舟1; 张 华2
(1.江苏大学附属武进医院 徐州医科大学武进临床学院消化内科,江苏 常州 213000; 2.江苏大学附属武进医院 徐州医科大学武进临床学院肿瘤科,江苏 常州 213000)
Author(s):
XU Min; WANG Yanzhou; ZHANG Hua
(Department of Gastroenterology,Wujin Hospital Affiliated to Jiangsu University,Changzhou 213000,China)
关键词:
结肠癌;  全身炎症反应指数;  控制营养状况评分;  无复发生存;  总生存;  预测价值
Keywords:
Colon cancer;  Systemic Inflammatory Response Index;  Controlling Nutritional Status score;  Recurrence-free survival;  Overall survival;  Predictive value
分类号:
R 735.35
DOI:
DOI:10.3969/j.issn.1000-7377.2023.11.023
文献标志码:
A
摘要:
目的:探讨全身炎性反应指数(SIRI)联合控制营养状况(CONUT)评分对结肠癌患者预后的预测价值。方法:选择结肠癌患者118例为结肠癌组,选择体检健康者75例为对照组。比较两组SIRI、CONUT评分。分析SIRI、CONUT评分与结肠癌患者临床病理特征的关系。采用Kaplan-Meier曲线和Cox回归分析SIRI、CONUT评分与结肠癌患者预后的关系。采用受试者工作特征(ROC)曲线分析SIRI和CONUT评分对结肠癌患者预后的预测价值。结果:结肠癌组SIRI、CONUT评分高于对照组(均P<0.05)。低分化、TNM Ⅲ-Ⅳ期、有神经侵犯的结肠癌患者SIRI、CONUT评分高于中高分化、TNMⅠ-Ⅱ期、无神经侵犯的结肠癌患者(均P<0.05)。高SIRI、高CONUT评分结肠癌患者无复发生存(RFS)、总生存(OS)率低于低SIRI、低CONUT评分结直癌患者(均P<0.05)。TNM Ⅲ-Ⅳ期、高SIRI、高CONUT评分是结肠癌患者预后的独立危险因素(均P<0.05)。SIRI联合CONUT评分预测结肠癌患者预后的曲线下面积高于两者单独预测(均P<0.05)。结论:结肠癌患者SIRI、CONUT评分升高,而高SIRI和CONUT评分与结肠癌高TNM分期、分化程度、神经侵犯以及低RFS、OS生存率有关,因此可作为预测结肠癌患者预后的标志物。
Abstract:
Objective:To investigate the predictive value of Systemic Inflammatory Response Index(SIRI)combined with Controlling Nutritional Status(CONUT)score in the prognosis of patients with colon cancer.Methods:A total of 118 patients with colon cancer were selected as the colon cancer group,and 75 healthy people were selected as the control group.SIRI and CONUT score were compared between the two groups.The relationship between SIRI,CONUT score and clinicopathological characteristics of colon cancer patients was analyzed.Kaplan-Meier curve and Cox regression were used to analyze the relationship between SIRI,CONUT score and the prognosis of patients with colon cancer.ROC curve was used to analyze the predictive value of SIRI and CONUT score for the prognosis of patients with colon cancer.Results:The SIRI and CONUT score of the colon cancer group were higher than those of the control group(all P<0.05).The SIRI and CONUT score of colon cancer patients with low differentiation,TNM Ⅲ-Ⅳ stage and nerve invasion were higher than those of colon cancer patients with moderately and high differentiation,TNM Ⅰ-Ⅱ stage and no nerve invasion(all P<0.05).The recurrence-free survival(RFS)and overall survival(OS)of colon cancer patients with high SIRI and high CONUT score were lower than those of colorectal cancer patients with low SIRI and low CONUT score(all P<0.05).TNM stage Ⅲ-Ⅳ,high SIRI and high CONUT score were independent risk factors for the prognosis of colon cancer patients(all P<0.05).The AUC of SIRI combined with CONUT score for predicting the prognosis of colon cancer patients was higher than that of SIRI or CONUT score alone(all P<0.05).Conclusion:SIRI and CONUT score are increased in patients with colon cancer,and high SIRI and CONUT score are related to high TNM stage,differentiation,nerve invasion,low RFS and OS survival rates of colon cancer,so they can be used as markers to predict the prognosis of patients with colon cancer.

参考文献/References:

[1] 顾 勇,杨 艳,符 翠,等.白藜芦醇对结肠癌恶性生物学行为的抑制作用研究[J].陕西医学杂志,2021,50(9):1072-1076.
[2] Chen JH,Zhai ET,Yuan YJ,et al.Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J].World J Gastroenterol,2017,23(34):6261-6272.
[3] Qiu C,Shi W,Wu H,et al.Identification of molecular subtypes and a prognostic signature based on inflammation-related genes in colon adenocarcinoma[J].Front Immunol,2021,12:769685.
[4] Zhu M,Chen L,Kong X,et al.The systemic inflammation response index as an independent predictor of survival in breast cancer patients:A retrospective study[J].Front Mol Biosci,2022,9:856064.
[5] Sun L,Hu W,Liu M,et al.High systemic inflammation response index(SIRI)indicates poor outcome in gallbladder cancer patients with surgical resection:A single institution experience in China[J].Cancer Res Treat,2020,52(4):1199-1210.
[6] Ravasco P.Nutrition in cancer patients[J].J Clin Med,2019,8(8):1211.
[7] Zhang Y,Chen Q,Lu C,et al.Prognostic role of controlling nutritional status score in hematological malignancies[J].Hematology,2022,27(1):653658.
[8] Takagi K,Domagala P,Polak WG,et al.Prognostic significance of the controlling nutritional status(CONUT)score in patients undergoing hepatectomy for hepatocellular carcinoma:A systematic review and meta-analysis[J].BMC Gastroenterol,2019,19(1):211.
[9] Ignacio-Ulíbarri J,González-Madrono A,Villar NG,et al.CONUT:A tool for controlling nutritional status.First validation in a hospital population[J].Nutr Hosp,2005,20(1):38-45.
[10] 徐建立,孙艳华,李 明,等.紫草素通过抑制上皮间质转化缓解结肠癌细胞5-氟尿嘧啶耐药[J].陕西中医,2022,43(3):296-300.
[11] 余 亮,郭 建,周国强,等.结肠癌患者血清微小RNA-193a-5p和微小RNA-139-5p表达检测及其对预后的影响[J].陕西医学杂志,2023,52(6):745-749.
[12] 董宏丹.黄芩苷对结肠癌HT-29细胞移植瘤小鼠IL-6/STAT3信号转导通路的影响[J].陕西中医,2021,42(6):696-700.
[13] Shah SC,Itzkowitz SH.Colorectal cancer in inflammatory bowel disease:Mechanisms and management[J].Gastroenterology,2022,162(3):715-730.
[14] Keller DS,Windsor A,Cohen R,et al.Colorectal cancer in inflammatory bowel disease:Review of the evidence[J].Tech Coloproctol,2019,23(1):3-13.
[15] Qi WX,Xiang Y,Zhao S,et al.Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab[J].Cancer Immunol Immunother,2021,70(11):3199-3206.
[16] Chao B,Ju X,Zhang L,et al.A novel prognostic marker systemic inflammation response index(SIRI)for operable cervical cancer patients[J].Front Oncol,2020,10:766.
[17] Hua X,Long ZQ,Huang X,et al.The preoperative systemic inflammation response index(SIRI)independently predicts survival in postmenopausal women with breast cancer[J].Curr Probl Cancer, 2020,44(4):100560.
[18] Xiao Y,Cong M,Li J,et al.Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation[J].Cancer Cell,2021,39(3):423-437.
[19] Olingy CE,Dinh HQ,Hedrick CC.Monocyte heterogeneity and functions in cancer[J].J Leukoc Biol,2019,106(2):309-322.
[20] Cupp MA,Cariolou M,Tzoulaki I,et al.Neutrophil to lymphocyte ratio and cancer prognosis:An umbrella review of systematic reviews and meta-analyses of observational studies[J].BMC Med,2020,18(1):360.
[21] Thanikachalam K,Khan G.Colorectal cancer and nutrition[J].Nutrients,2019,11(1):164.
[22] Jiang Y,Xu D,Song H,et al.Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer:A systematic review and meta-analysis[J].BMJ Open,2021,11(9):48324.
[23] Iseki Y,Shibutani M,Maeda K,et al.Impact of the preoperative controlling nutritional status(CONUT)score on the survival after curative surgery for colorectal cancer[J].PLoS One,2015,10(7):132488.
[24] Takagi K,Domagala P,Polak WG,et al.Prognostic significance of the controlling nutritional status(CONUT)score in patients undergoing gastrectomy for gastric cancer:A systematic review and meta-analysis[J].BMC Surg,2019,19(1):129.
[25] Kubat M,Bozkirli BO,Yazicioglu MO,et al.Does albumin level change the strength of the memorial sloan kettering cancer center nomogram used to predict 5-year survival in patients with colon cancer[J].J Coll Physicians Surg Pak,2022,32(4):467-472.
[26] Silva A,Pereira SS,Monteiro MP,et al.Effect of metabolic syndrome and individual components on colon cancer characteristics and prognosis[J].Front Oncol,2021,11:631257.

相似文献/References:

[1]王 雄,张月飞,赵东雄,等.初诊结肠癌患者血小板相关指标与临床分期关系分析[J].陕西医学杂志,2019,(12):1676.
[2]龚 磊,吕真冰,喻 晶,等.SIRT1、Phospho-SIRT1在结肠癌组织中的表达及临床意义*[J].陕西医学杂志,2020,49(3):274.
　GONG Lei,LV Zhenbing,YU Jing,et al.Expression and clinical significance of SIRT1 and Phospho-SIRT1 in colon cancer tissues[J].,2020,49(11):274.
[3]冯 婷,刘 霞,高立勇.叉头框转录因子O亚族3a对结肠癌SW620细胞的影响及机制研究[J].陕西医学杂志,2021,50(9):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
　FENG Ting,LIU Xia,GAO Liyong.Effect and mechanism of FOXO3a on colon cancer SW620 cells[J].,2021,50(11):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
[4]顾 勇,杨 艳,符 翠,等.白藜芦醇对结肠癌恶性生物学行为的抑制作用研究[J].陕西医学杂志,2021,50(9):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
　GU Yong,YANG Yan,FU Cui,et al.Inhibitory effect of resveratrol on malignant biological behavior of colon cancer[J].,2021,50(11):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
[5]余 亮,郭 建,周国强,等.结肠癌患者血清微小RNA-193a-5p和微小RNA-139-5p表达检测及其对预后的影响[J].陕西医学杂志,2023,52(6):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
　YU Liang,GUO Jian,ZHOU Guoqiang,et al.Expression of serum miR-193a-5p and miRNA-139-5p in patients with colon cancer and their effects on prognosis[J].,2023,52(11):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
[6]王瑜崴,李 濛,康 博,等.结肠癌组织微小RNA-3607-3p、细胞周期蛋白E2表达及其与患者术后5年预后关系研究[J].陕西医学杂志,2024,(8):1124.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.026]
　WANG Yuwei,LI Meng,KANG Bo,et al.Expression of microRNA-3607-3p and cyclin E2 in colon cancer tissues and their relationship with 5-year prognosis of patients after surgery[J].,2024,(11):1124.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.026]
[7]谭 蕊,李 论,罗 登.飞燕草素调控RhoA/ROCK信号通路对结肠癌细胞生物学行为及血管生成拟态形成的影响[J].陕西医学杂志,2024,(11):1468.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.006]
　TAN Rui,LI Lun,LUO Deng.Effects of delphinidin on the biological behavior and vasculogenic mimicry formation of colon cancer cells by regulating the RhoA/ROCK signaling pathway[J].,2024,(11):1468.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.006]

备注/Memo

备注/Memo:
基金项目:江苏省卫生和计划生育委员会医学科研项目(H20180086)
更新日期/Last Update: 2023-11-06